New tests launched in November
New Tests
In November 2022, Mayo Clinic Laboratories announced eighteen new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
The new tests that launched in November 2022 by Mayo Clinic Laboratories:
CDPCR | Clostridioides difficile Toxin, PCR, Feces
This test is intended for sensitive, specific, and rapid diagnosis of Clostridioides (Clostridium) difficile-associated diarrhea and pseudomembranous colitis.
H1083 | HIK1083 Immunostain, Technical Component Only
This test is useful for the diagnosis of gastric-type endocervical adenocarcinoma.
IDH2 | IHD2, R172K Mutation, Immunostain, Technical Component Only
This test is intended to be used for the identification of IDH2 R172K mutant protein in angioimmunoblastic T-cell lymphoma or acute myeloid leukemia.
MALP | Malabsorption Evaluation Panel, Feces
This test is useful for the evaluation of patients with suspected malabsorption, as suggested by chronic diarrhea, unexplained weight loss, or nutritional deficiencies.
MCLBP | MayoComplete Liquid Biopsy Panel, Next-Generation Sequencing, Cell-Free DNA
This test is intended to be used as an alternative to invasive tissue biopsies to assist in tumor profiling for diagnosis, predicting prognosis, and identifying targeted therapies for the treatment and management of patients with solid tumors.
MDSDF | Myelodysplastic Syndrome (MDS), Diagnostic FISH, Varies
This test is useful for detecting a neoplastic clone associated with the common chromosome abnormalities seen in patients with myelodysplastic syndromes or other myeloid malignancies using a laboratory-designated probe set algorithm.
MDSMF | Myelodysplastic Syndrome (MDS), Specified FISH, Varies
This test is useful for detecting a neoplastic clone associated with the common chromosome abnormalities seen in patients with myelodysplastic syndromes or other myeloid malignancies using client specified probes.
POU2F | POU2F3 Immunostain, Technical Component Only
This test is intended to be used for the diagnosis of a variant of small cell lung carcinoma.
SV40 | SV40 Immunostain, Technical Component Only
This test is intended to be used for identifying BK or JC polyomavirus.
TB1LN | Antimicrobial Susceptibility, Mycobacterium tuberculosis Complex, First Line, Varies
This test is intended to be used for rapid, qualitative susceptibility testing of Mycobacterium tuberculosis complex isolates growing in pure culture as well as confirming the emergence of drug resistance.
TBPZA | Susceptibility, Mycobacterium tuberculosis Complex, Pyrazinamide, Varies
This test is intended for susceptibility testing of Mycobacterium tuberculosis complex isolates growing in pure culture against pyrazinamide.
VZIKM | Zika Virus, IgM Antibody Capture ELISA, Serum
This test is intended to be used for screening for the presence of IgM-class antibodies to Zika virus.
This test is not recommended for asymptomatic couples attempting conception.
ZW342 | Miscellaneous MDX Health Inc.
In addition to these tests, the department also announced several test changes. Click the links below to view test changes announced by Mayo Clinic Laboratories: